On Jul 19, 2021, Quit Genius closed a Series B round and raised $64,000,000 from Atomico, Kinnevik AB, Octopus Ventures, StartUp Health, Triple Point Ventures, featuring lead investors Atomico, Kinnevik AB.
About the company: Quit Genius is located in the UK and in the United States, North America. “Conquer addiction in your workforce with Quit Genius, the worldâs leading digital clinic for multiple addictions. Personalized addiction treatment from the privacy of your employee’s home.” The B2B2C startup is the world’s first digital clinic delivering a comprehensive Medication-Assisted Treatment program for multiple addictions, 100% virtually. Quit Genius grew revenue by 10x in the past 12 months, and now partners with 55 employer and health plan clients, covering 2.1M lives. Its headcount grew by 4x in the past year.
Company website: www.quitgenius.com
